[
  {
    "sentence": "Analyses of each clinical group for the 2 cognitive domains by aggressive and indolent disease presentation did not show a difference in prevalence except for the 5-word delayed recall test, which was more prevalent among patients with aggressive myeloma (12 of 58 patients [20.7%] vs 5 of 64 patients [7.8%]; P = .04).Cognitive Impairment and Mortality\nAmong all patients, probable impairment on the 5-word delayed recall test was associated with an increased risk of overall mortality (median survival, 10.9 [SD, 12.9] vs 12.2 [SD, 14.7] months; log-rank P < .001) (Figure 1A), whereas probable impairment on the CIB test was not associated with survival (log-rank P = .10) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among patients with aggressive disease, decreased survival was seen among those with probable impairment on the 5-word delayed recall test only (log-rank P < .001) (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among those with indolent disease, only impairment on the 5-word delayed recall test was associated with worse survival (log-rank P = .01) (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Among patients treated with intensive regimens, decreased survival was seen for probable cognitive impairment on the 5-word delayed recall test (log-rank P < .001) and CIB test (log-rank P = .03) (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Analyses of each clinical group for the 2 cognitive domains by aggressive and indolent disease presentation did not show a difference in prevalence except for the 5-word delayed recall test, which was more prevalent among patients with aggressive myeloma (12 of 58 patients [20.7%] vs 5 of 64 patients [7.8%]; P = .04).Cognitive Impairment and Mortality\nAmong all patients, probable impairment on the 5-word delayed recall test was associated with an increased risk of overall mortality (median survival, 10.9 [SD, 12.9] vs 12.2 [SD, 14.7] months; log-rank P < .001) (Figure 1A), whereas probable impairment on the CIB test was not associated with survival (log-rank P = .10) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among patients with aggressive disease, decreased survival was seen among those with probable impairment on the 5-word delayed recall test only (log-rank P < .001) (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among those with indolent disease, only impairment on the 5-word delayed recall test was associated with worse survival (log-rank P = .01) (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Among patients treated with intensive regimens, decreased survival was seen for probable cognitive impairment on the 5-word delayed recall test (log-rank P < .001) and CIB test (log-rank P = .03) (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Analyses of each clinical group for the 2 cognitive domains by aggressive and indolent disease presentation did not show a difference in prevalence except for the 5-word delayed recall test, which was more prevalent among patients with aggressive myeloma (12 of 58 patients [20.7%] vs 5 of 64 patients [7.8%]; P = .04).Cognitive Impairment and Mortality\nAmong all patients, probable impairment on the 5-word delayed recall test was associated with an increased risk of overall mortality (median survival, 10.9 [SD, 12.9] vs 12.2 [SD, 14.7] months; log-rank P < .001) (Figure 1A), whereas probable impairment on the CIB test was not associated with survival (log-rank P = .10) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among patients with aggressive disease, decreased survival was seen among those with probable impairment on the 5-word delayed recall test only (log-rank P < .001) (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among those with indolent disease, only impairment on the 5-word delayed recall test was associated with worse survival (log-rank P = .01) (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Among patients treated with intensive regimens, decreased survival was seen for probable cognitive impairment on the 5-word delayed recall test (log-rank P < .001) and CIB test (log-rank P = .03) (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Analyses of each clinical group for the 2 cognitive domains by aggressive and indolent disease presentation did not show a difference in prevalence except for the 5-word delayed recall test, which was more prevalent among patients with aggressive myeloma (12 of 58 patients [20.7%] vs 5 of 64 patients [7.8%]; P = .04).Cognitive Impairment and Mortality\nAmong all patients, probable impairment on the 5-word delayed recall test was associated with an increased risk of overall mortality (median survival, 10.9 [SD, 12.9] vs 12.2 [SD, 14.7] months; log-rank P < .001) (Figure 1A), whereas probable impairment on the CIB test was not associated with survival (log-rank P = .10) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among patients with aggressive disease, decreased survival was seen among those with probable impairment on the 5-word delayed recall test only (log-rank P < .001) (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among those with indolent disease, only impairment on the 5-word delayed recall test was associated with worse survival (log-rank P = .01) (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Among patients treated with intensive regimens, decreased survival was seen for probable cognitive impairment on the 5-word delayed recall test (log-rank P < .001) and CIB test (log-rank P = .03) (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Analyses of each clinical group for the 2 cognitive domains by aggressive and indolent disease presentation did not show a difference in prevalence except for the 5-word delayed recall test, which was more prevalent among patients with aggressive myeloma (12 of 58 patients [20.7%] vs 5 of 64 patients [7.8%]; P = .04).Cognitive Impairment and Mortality\nAmong all patients, probable impairment on the 5-word delayed recall test was associated with an increased risk of overall mortality (median survival, 10.9 [SD, 12.9] vs 12.2 [SD, 14.7] months; log-rank P < .001) (Figure 1A), whereas probable impairment on the CIB test was not associated with survival (log-rank P = .10) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among patients with aggressive disease, decreased survival was seen among those with probable impairment on the 5-word delayed recall test only (log-rank P < .001) (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among those with indolent disease, only impairment on the 5-word delayed recall test was associated with worse survival (log-rank P = .01) (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Among patients treated with intensive regimens, decreased survival was seen for probable cognitive impairment on the 5-word delayed recall test (log-rank P < .001) and CIB test (log-rank P = .03) (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Analyses of each clinical group for the 2 cognitive domains by aggressive and indolent disease presentation did not show a difference in prevalence except for the 5-word delayed recall test, which was more prevalent among patients with aggressive myeloma (12 of 58 patients [20.7%] vs 5 of 64 patients [7.8%]; P = .04).Cognitive Impairment and Mortality\nAmong all patients, probable impairment on the 5-word delayed recall test was associated with an increased risk of overall mortality (median survival, 10.9 [SD, 12.9] vs 12.2 [SD, 14.7] months; log-rank P < .001) (Figure 1A), whereas probable impairment on the CIB test was not associated with survival (log-rank P = .10) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among patients with aggressive disease, decreased survival was seen among those with probable impairment on the 5-word delayed recall test only (log-rank P < .001) (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among those with indolent disease, only impairment on the 5-word delayed recall test was associated with worse survival (log-rank P = .01) (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Among patients treated with intensive regimens, decreased survival was seen for probable cognitive impairment on the 5-word delayed recall test (log-rank P < .001) and CIB test (log-rank P = .03) (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Analyses of each clinical group for the 2 cognitive domains by aggressive and indolent disease presentation did not show a difference in prevalence except for the 5-word delayed recall test, which was more prevalent among patients with aggressive myeloma (12 of 58 patients [20.7%] vs 5 of 64 patients [7.8%]; P = .04).Cognitive Impairment and Mortality\nAmong all patients, probable impairment on the 5-word delayed recall test was associated with an increased risk of overall mortality (median survival, 10.9 [SD, 12.9] vs 12.2 [SD, 14.7] months; log-rank P < .001) (Figure 1A), whereas probable impairment on the CIB test was not associated with survival (log-rank P = .10) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among patients with aggressive disease, decreased survival was seen among those with probable impairment on the 5-word delayed recall test only (log-rank P < .001) (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among those with indolent disease, only impairment on the 5-word delayed recall test was associated with worse survival (log-rank P = .01) (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Among patients treated with intensive regimens, decreased survival was seen for probable cognitive impairment on the 5-word delayed recall test (log-rank P < .001) and CIB test (log-rank P = .03) (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Analyses of each clinical group for the 2 cognitive domains by aggressive and indolent disease presentation did not show a difference in prevalence except for the 5-word delayed recall test, which was more prevalent among patients with aggressive myeloma (12 of 58 patients [20.7%] vs 5 of 64 patients [7.8%]; P = .04).Cognitive Impairment and Mortality\nAmong all patients, probable impairment on the 5-word delayed recall test was associated with an increased risk of overall mortality (median survival, 10.9 [SD, 12.9] vs 12.2 [SD, 14.7] months; log-rank P < .001) (Figure 1A), whereas probable impairment on the CIB test was not associated with survival (log-rank P = .10) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among patients with aggressive disease, decreased survival was seen among those with probable impairment on the 5-word delayed recall test only (log-rank P < .001) (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among those with indolent disease, only impairment on the 5-word delayed recall test was associated with worse survival (log-rank P = .01) (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Among patients treated with intensive regimens, decreased survival was seen for probable cognitive impairment on the 5-word delayed recall test (log-rank P < .001) and CIB test (log-rank P = .03) (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Analyses of each clinical group for the 2 cognitive domains by aggressive and indolent disease presentation did not show a difference in prevalence except for the 5-word delayed recall test, which was more prevalent among patients with aggressive myeloma (12 of 58 patients [20.7%] vs 5 of 64 patients [7.8%]; P = .04).Cognitive Impairment and Mortality\nAmong all patients, probable impairment on the 5-word delayed recall test was associated with an increased risk of overall mortality (median survival, 10.9 [SD, 12.9] vs 12.2 [SD, 14.7] months; log-rank P < .001) (Figure 1A), whereas probable impairment on the CIB test was not associated with survival (log-rank P = .10) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among patients with aggressive disease, decreased survival was seen among those with probable impairment on the 5-word delayed recall test only (log-rank P < .001) (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among those with indolent disease, only impairment on the 5-word delayed recall test was associated with worse survival (log-rank P = .01) (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Among patients treated with intensive regimens, decreased survival was seen for probable cognitive impairment on the 5-word delayed recall test (log-rank P < .001) and CIB test (log-rank P = .03) (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Cognitive Impairment and Mortality\nAmong all patients, probable impairment on the 5-word delayed recall test was associated with an increased risk of overall mortality (median survival, 10.9 [SD, 12.9] vs 12.2 [SD, 14.7] months; log-rank P < .001) (Figure 1A), whereas probable impairment on the CIB test was not associated with survival (log-rank P = .10) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among patients with aggressive disease, decreased survival was seen among those with probable impairment on the 5-word delayed recall test only (log-rank P < .001) (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among those with indolent disease, only impairment on the 5-word delayed recall test was associated with worse survival (log-rank P = .01) (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Figure 2.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Cross-hatch indicates censored data.Among patients treated with intensive regimens, decreased survival was seen for probable cognitive impairment on the 5-word delayed recall test (log-rank P < .001) and CIB test (log-rank P = .03) (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Among all patients, probable impairment on the 5-word delayed recall test was associated with an increased risk of overall mortality (median survival, 10.9 [SD, 12.9] vs 12.2 [SD, 14.7] months; log-rank P < .001) (Figure 1A), whereas probable impairment on the CIB test was not associated with survival (log-rank P = .10) (Figure 1B).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel A",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel B",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among patients with aggressive disease, decreased survival was seen among those with probable impairment on the 5-word delayed recall test only (log-rank P < .001) (Figure 2A).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel A",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among those with indolent disease, only impairment on the 5-word delayed recall test was associated with worse survival (log-rank P = .01) (Figure 2C).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "Panel C",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Among patients treated with intensive regimens, decreased survival was seen for probable cognitive impairment on the 5-word delayed recall test (log-rank P < .001) and CIB test (log-rank P = .03) (Figure 3).",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  }
]